Denali Therapeutics, US

Ryan J. Watts, PhD is the President and Chief Executive Officer of Denali Therapeutics, a company founded to discover and develop medicines for neurodegenerative diseases. He is a co-founder and a member of the Board of Directors.

Dr. Watts previously served as Director of the Department of Neuroscience at Genentech. During his tenure there, he led the company’s entry into neuroscience, advancing multiple programs from discovery to clinical testing. The Watts laboratory focused on drug discovery for cancer and Alzheimer’s disease, with an emphasis on understanding mechanisms of neurodegeneration guided by human genetics. His lab also invented methods for delivery of therapeutics across the blood-brain barrier into the brain.

Dr. Watts obtained his Ph.D. from Stanford University’s Department of Biological Sciences.

More info:

Personal website

Speaker at
24-25 May 2018, Ghent, Belgium